Literature DB >> 20621710

Where to go next with neuroprotection in multiple sclerosis?

Franz Fazekas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20621710     DOI： 10.1016/S1474-4422(10)70133-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  1 in total

1.  Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial.

Authors:  Judith Bellmann-Strobl; Friedemann Paul; Jens Wuerfel; Jan Dörr; Carmen Infante-Duarte; Elmira Heidrich; Benedict Körtgen; Alexander Brandt; Caspar Pfüller; Helena Radbruch; Rebekka Rust; Volker Siffrin; Orhan Aktas; Christoph Heesen; Jürgen Faiss; Frank Hoffmann; Mario Lorenz; Benno Zimmermann; Sergiu Groppa; Klaus-Dieter Wernecke; Frauke Zipp
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.